title: Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation.
abstract: Increasing evidence indicates that local neurogenic inflammation, possibly in response to different stimuli, may be involved in sensory nerve sensitization, migraine generation and some other precipitating events leading to neuronal dysfunction in the brain. In addition, mast cells generate eicosanoids that are linked to asthma and other inflammatory diseases. Regulated upon activation, normal T-cell expressed and secreted (RANTES) is a small protein and a prototype member of the CC chemokine-beta subfamily with chemoattractant and inflammatory properties. In this study we used the RBL-2H3 cell line to determine whether or not these cells generate prostaglandin D2 (PGD2) after treatment with RANTES. After 4 hours of incubation, RBL-2H3 cells cultured with RANTES at 20 ng/mL released large amounts of PGD2 in a dose-response manner compared to control. Moreover, RBL-treated RANTES generated a large quantity of histamine. Our study confirms once again the proinflammatory action of RANTES, in this case acting on the stimulation of the arachidonic acid cascade product PGD2.
authors.affiliation: Department of Medicine and Aging, Medical School, University of Chieti-Pescara, Chieti, Italy. pconti@unich.it
authors.forename: M L
authors.initials: ML
authors.lastname: Castellani
authors.forename: C
authors.initials: C
authors.lastname: Petrarca
authors.forename: S
authors.initials: S
authors.lastname: Frydas
authors.forename: C M
authors.initials: CM
authors.lastname: Conti
authors.forename: V
authors.initials: V
authors.lastname: Salini
authors.forename: P
authors.initials: P
authors.lastname: Conti
authors.forename: L N
authors.initials: LN
authors.lastname: Shanmugham
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D018946:Chemokine CCL5 / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006636:Histamine Release / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D015471:Leukemia, Basophilic, Acute / Q000378:metabolism*; D015230:Prostaglandin D2 / Q000096:biosynthesis*; D051381:Rats
chemical_list: D018946:Chemokine CCL5; D015230:Prostaglandin D2; D007213:Indomethacin